In this study, TC-1-GLUC-LMP2 model tumor cells were constructed to stably and efficiently express LMP2 and GLuc to provide candidate model tumor cells to evaluate EBV LMP2-associated tumor vaccines. This evidence concerns the gene PSMB9 and neoplasm.